Please login to the form below

Not currently logged in
Email:
Password:

Shire’s Dr Armin Reininger moves to Sobi

Appointed as senior vice president, head of global medical and scientific affairs

Sobi Dr Armin ReiningerStockholm-based Sobi has appointed Dr Armin Reininger as a senior vice president and head of global medical and scientific affairs.

Dr Reininger joins the rare diseases specialist from Shire, where he most recently served as head of medical affairs for haematology, EMEA at Baxalta, having first joined Baxter as head of global medical affairs for haemophilia.

Prior to this, Dr Reininger held several academic research and clinical positions at the Ludwig Maximillian University in Munich, Germany, The Scripps Research Institute, and Harvard Medical School.

Geoffrey McDonough, president and chief executive officer at Sobi, said: “We are truly delighted to welcome Armin to Sobi.

“Armin will apply his deep experience as an industry leader and academic in haemophilia to our team, as well as his global experience in medical scientific affairs to our stakeholders.”

17th January 2017

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics